1-Methyl-1H-indazol-5-yl-5-boronic acid, 97.0%, 100g

5-Bromo-3-(trifluoromethyl)-1H-pyrazole, 95.0%, 5g

4-(1-BENZYLPIPERIDIN-4-YLAMINO)-2-(METHYLTHIO)PYRIMIDINE-5-CARBOXYLIC ACID, 95.0%, 250mg

(3R,4S)-tert-Butyl 3,4-dihydroxypyrrolidine-1-carboxylate, 97.0%, 1g

7-Fluoroisoquinoline, 95.0%, 1g

(1R,5S)-endo-8-Benzyl-8-azabicyclo[3.2.1]octan-3-amine, 95.0%, 1g

2-HYDROXY-2-(2-METHYLPHENYL)ETHYLAMINE OXALATE, 95.0%, 1g

tert-Butyl (3-bromo-4-fluorophenyl)carbamate, 95.0%, 1g

3-Borono-4-methylbenzoic acid, 95.0%, 5g

(S)-2,2-diphenyl-2-(1-tosylpyrrolidin-3-yl)acetonitrile, 98%, 5g

Pipettes sérologiques CELLSTAR®, 5 ml, 4 x (50 x 1), 200 pièces

[S(R)]-N-[(S)-[3-(Benzyloxy)-2-(dicyclohexylphosphino)phenyl]-(2-naphthalenyl)methyl]-N,2-dimethyl-2-propanesulfinamide, 95%, 25mg

DAPHNORETIN, 95%, 250mg